Risultati della ricerca - Hironori Harada
- Mostra 1 - 20 risultati su 24
- Vai alla pagina seguente
-
1
Hypoxia/pseudohypoxia‐mediated activation of hypoxia‐inducible factor‐1α in cancer di Yoshihiro Hayashi, Asumi Yokota, Hironori Harada, Gang Huang
Pubblicazione 2019Revisão -
2
-
3
-
4
-
5
-
6
Identification of immature and mature myeloma cells in the bone marrow of human myelomas di MM Kawano, N Huang, Hironori Harada, Yuka Harada, Ayako Sakai, H Tanaka, K Iwato, A Kuramoto
Pubblicazione 1993Artigo -
7
The loss of Ezh2 drives the pathogenesis of myelofibrosis and sensitizes tumor-initiating cells to bromodomain inhibition di Goro Sashida, Changshan Wang, T. Tomioka, Motohiko Oshima, Kazumasa Aoyama, Akinori Kanai, Makiko Mochizuki‐Kashio, Hironori Harada, Kazuya Shimoda, Atsushi Iwama
Pubblicazione 2016Artigo -
8
-
9
Expression of a Knocked-In AML1-ETO Leukemia Gene Inhibits the Establishment of Normal Definitive Hematopoiesis and Directly Generates Dysplastic Hematopoietic Progenitors di Tsukasa Okuda, Zhongling Cai, Shouli Yang, Noel Lenny, Chuhl-joo Lyu, Jan M. A. van Deursen, Hironori Harada, James R. Downing
Pubblicazione 1998Artigo -
10
Expression of a Knocked-In AML1-ETO Leukemia Gene Inhibits the Establishment of Normal Definitive Hematopoiesis and Directly Generates Dysplastic Hematopoietic Progenitors di Tsukasa Okuda, Zhongling Cai, Shouli Yang, Noel Lenny, Chuhl Joo Lyu, Jan M. A. van Deursen, Hironori Harada, James R. Downing
Pubblicazione 1998Artigo -
11
ETO, a Target of t(8;21) in Acute Leukemia, Makes Distinct Contacts with Multiple Histone Deacetylases and Binds mSin3A through Its Oligomerization Domain di Joseph M. Amann, John Nip, David K. Strom, Bart Lutterbach, Hironori Harada, Noel Lenny, James R. Downing, Shari Meyers, Scott W. Hiebert
Pubblicazione 2001Artigo -
12
Two types of C/EBPα mutations play distinct but collaborative roles in leukemogenesis: lessons from clinical data and BMT models di Naoko Kato, Jiro Kitaura, Noriko Doki, Yukiko Komeno, Naoko Watanabe‐Okochi, Katsuhiro Togami, Fumio Nakahara, Toshihiko Oki, Yutaka Enomoto, Yumi Fukuchi, Hideaki Nakajima, Yuka Harada, Hironori Harada, Toshio Kitamura
Pubblicazione 2010Artigo -
13
Hes1 immortalizes committed progenitors and plays a role in blast crisis transition in chronic myelogenous leukemia di Fumio Nakahara, Mamiko Sakata‐Yanagimoto, Yukiko Komeno, Naoko Kato, Tomoyuki Uchida, Kyoko Haraguchi, Keiki Kumano, Yuka Harada, Hironori Harada, Jiro Kitaura, Seishi Ogawa, Mineo Kurokawa, Toshio Kitamura, Shigeru Chiba
Pubblicazione 2009Artigo -
14
Conversion of antigen-specific effector/memory T cells into Foxp3-expressing T <sub>reg</sub> cells by inhibition of CDK8/19 di Masahiko Akamatsu, Norihisa Mikami, Naganari Ohkura, Ryoji Kawakami, Yohko Kitagawa, Atsushi Sugimoto, Keiji Hirota, Naoto Nakamura, Satoru Ujihara, T. Kurosaki, Hisao Hamaguchi, Hironori Harada, Guliang Xia, Yoshiaki Morita, Ichiro Aramori, Shuh Narumiya, Shimon Sakaguchi
Pubblicazione 2019Artigo -
15
Recurrent CDC25C mutations drive malignant transformation in FPD/AML di Akihide Yoshimi, Takashi Toya, Masahito Kawazu, Toshihide Ueno, Ayato Tsukamoto, Hiromitsu Iizuka, Masahiro Nakagawa, Yasuhito Nannya, Shunya Arai, Hironori Harada, Kensuke Usuki, Yasuhide Hayashi, Etsuro Ito, Keita Kirito, Hideaki Nakajima, Motoshi Ichikawa, Hiroyuki Mano, Mineo Kurokawa
Pubblicazione 2014Artigo -
16
Ezh2 loss promotes development of myelodysplastic syndrome but attenuates its predisposition to leukaemic transformation di Goro Sashida, Hironori Harada, Hirotaka Matsui, Motohiko Oshima, Makiko Yui, Yuka Harada, Satomi Tanaka, Makiko Mochizuki‐Kashio, Changshan Wang, Atsunori Saraya, Tomoya Muto, Yoshihiro Hayashi, Kotaro Suzuki, Hiroshi Nakajima, Toshiya Inaba, Haruhiko Koseki, Gang Huang, Toshio Kitamura, Atsushi Iwama
Pubblicazione 2014Artigo -
17
A MAP1B–cortactin–Tks5 axis regulates TNBC invasion and tumorigenesis di Hiroki Inoue, Taku Kanda, Gakuto Hayashi, Ryota Munenaga, Masayuki Yoshida, K. Hasegawa, Takuya Miyagawa, Yukiya Kurumada, Jumpei Hasegawa, Tomoyuki Wada, M. Horiuchi, Yasuhiro Yoshimatsu, Fumiko Itoh, Yuki Maemoto, Kohei Arasaki, Yuichi Wakana, Tetsuro Watabe, Hiromichi Matsushita, Hironori Harada, Mitsuo Tagaya
Pubblicazione 2024Artigo -
18
Impaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD/AML patients di Masatoshi Sakurai, Hiroyoshi Kunimoto, Naohide Watanabe, Yumi Fukuchi, Shinsuke Yuasa, Satoshi Yamazaki, Toshinobu Nishimura, Ken Sadahira, Keiichi Fukuda, Hideyuki Okano, Hiromitsu Nakauchi, Yasuyoshi Morita, Itaru Matsumura, Ko Kudo, Etsuro Ito, Yasuhiro Ebihara, Kohichiro Tsuji, Yuka Harada, Hironori Harada, Shinichiro Okamoto, Hideaki Nakajima
Pubblicazione 2014Artigo -
19
SETBP1 mutations drive leukemic transformation in ASXL1-mutated MDS di Daichi Inoue, Jiro Kitaura, Hirotaka Matsui, Hsin‐An Hou, Wen‐Chien Chou, Akiko Nagamachi, Kimihito C. Kawabata, Katsuhiro Togami, Reina Nagase, Saburo Horikawa, Makoto Saika, J-B Micol, Yasutaka Hayashi, Yuka Harada, Hironori Harada, Toshiya Inaba, Hwei‐Fang Tien, Omar Abdel‐Wahab, Toshio Kitamura
Pubblicazione 2014Artigo -
20
Changes in donor lymphocyte infusion for relapsed patients post-hematopoietic stem cell transplantation: a 30-year single-center experience di Yusuke Uchibori, Shuhei Kurosawa, Yuho Najima, Kyoko Haraguchi, Daichi Sadato, Chizuko Hirama, Yasutaka Sadaga, Kaori Kondo, Chika Kato, Satoshi Sakai, Yasuhiro Kambara, Fumihiko Ouchi, Masashi Shimabukuro, Atsushi Jinguji, Naoki Shingai, Takashi Toya, Hiroaki Shimizu, Takeshi Kobayashi, Hironori Harada, Yuka Harada, Yoshiki Okuyama, Noriko Doki
Pubblicazione 2025Artigo
Strumenti per la ricerca:
Soggetti correlati
Biology
Cancer research
Genetics
Gene
Immunology
Cell biology
Stem cell
Leukemia
Myeloid
Bone marrow
Haematopoiesis
Myeloid leukemia
Molecular biology
Mutation
Progenitor cell
RUNX1
Medicine
Epigenetics
Gene expression
Myelodysplastic syndromes
Biochemistry
EZH2
Histone
PRC2
Point mutation
Signal transduction
Transcription factor
CD34
Cancer
Cell